Daily pill to help keep weight off after stopping obesity jabs BBC
Lilly’s Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials investor.lilly.com
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial Nature
Patients don’t regain much weight switching from injections to Lilly’s weight-loss pill, study finds Reuters
Oral Orforglipron Effective in Older Adults With Obesity Medscape